Skip navigation
Agenda

Practical Strategies for Direct Contracting, Hospital Sales and Data Utilization to Drive Product Success in Evolving Health Systems

August 16-17, 2017
  • Philadelphia, PA

Agenda

Want more agenda details? Download the brochure.

DAY ONE Wednesday, August 16, 2017

7:00

Registration and Continental Breakfast

8:00

Chairperson’s Welcome and Opening Remarks

Gerard Taglianetti
Director, Team Leader, U.S. Payer & Channel Access
Pfizer, Inc

Define Models and Establish Strategies for
Mutually-Beneficial Partnering Relationships

8:15

KEYNOTE PANEL Understanding the Rising Influence of IDNs and HMOs and the Impact on the Healthcare Ecosystem

MODERATOR:

Sarah Foss, PhD
Senior Manager, IDN Message Monitor, Managed Care Message Monitor
Zitter Health Insights

PANELISTS:

Marc O’Connor
Principal, Chief Operating Officer
Curant Health

Jerry Buller
Director, Specialty Pharmacy Services
Vanderbilt University Medical Center

Gerard Taglianetti
Director, Team Leader, U.S. Payer & Channel Access
Pfizer, Inc

John Robicsek
Assistant Vice President, Strategy,
Business and Program Development, Pharmacy Administration
Carolinas Healthcare System

9:15

How Enhancing the Account Management Model Improves IDN Collaboration

Scott Bischoff
Senior Manager, Health Systems Marketing
Teva Pharmaceuticals

Christopher Lisanti
Managing Partner
Exequor Group

10:00

Networking and Refreshment Break

10:30

EXTENDED SESSION Starting from Scratch — Create a Focused Sales Approach

Creating effective relationships with IDNs requires manufacturers to reform their thinking about the customer. This session takes a step-by-step, internal and external approach to engaging large hospital systems and IDNs for the betterment of your product.

I. Choose the Right Partners for Your Brand

II. Identify the Key Decision Makers

III. Build Up Your Team Competency

IV. Become More Customer-Centric — What Does That Mean?

Jeff Prewett
Senior National Account Director - Oncology GPO & IDN
Lilly USA, LLC

Mark Fisher
Senior Manager, Organized Customer Group Commercial Effectiveness, Diabetes/CV Sales
Sanofi US

Wolfgang Freund
Area Sales Director
Sunovion Pharmaceuticals, Inc.

Jeremy Tatum
Director of Sales and Strategic Accounts
American Regent, Inc.

Leverage Data Analytics for
Better Partnership Decision-Making

11:30

Examine Key Characteristics for Defining IDNs and Major Factors for Their Development

Mark Cherry
Principal Analyst, Market Access Insights
Decision Resources Group

12:15

Networking Luncheon

1:30

Gain Insights into Provider Care Coordination and Population Health Management

William T. Lee, DPh, MPA, FASCP
Pharmacy System Director
Carilion Clinic Healthcare System

2:15

Systems of Care — Understanding Network Affiliations and What They May Mean for Your IDN Strategy

Don DeStefano
Director, Life Sciences
LexisNexis Risk Solutions

3:00

Networking and Refreshment Break

3:30

Lessons Learned to Date —
What Makes for a Successful Value Exchange Between Pharma and IDNs?

Will Rose
Managing Consultant
Capgemini Consulting

4:15

Examine Health System Partnerships with External Pharmacies

William Roth
Founding Partner
Blue Fin Group

Andy Pulvermacher
Principal Consultant
Blue Fin Group

5:00

Close of Day One

Networking, Wine and Cheese Reception immediately following the close of day one

DAY TWO Thursday, August 17, 2017

7:00

Continental Breakfast

7:45

Chairperson’s Review of Day One

Gerard Taglianetti
Director, Team Leader, U.S. Payer & Channel Access
Pfizer, Inc

The IDN Evolution and What It Means for Patients

8:00

Importance of Data Visibility to Improve Patient Care and Outcomes

Tom Renshaw, RPh, MCSD, MBA
Senior Director, Business Solutions
Apexus

Rich Gliklich, MD
CEO
OM1 Health

8:45

Biologics and Biosimilars — Regulatory Requirements Impacting EHRs and Pharmacy Systems Used by IDNs

Thomas Felix, MD
R&D Policy, Intercontinental Region (Global Regulatory Affairs and Safety)
Amgen

Pooja Babbrah
Senior Consultant and Practice Lead
Point-of-Care Partners

9:30

From Diagnosis to Delivery — Disruptive Innovation in a Specialty Pharmacy

JoAnn Stubbings, BSPharm, MHCA
Assistant Director, Specialty Pharmacy Services, Ambulatory Care Pharmacy Department
University of Illinois at Chicago College of Pharmacy

10:15

Networking and Refreshment Break

10:45

UMASS MEMORIAL Follow the Patient Journey through an Integrated Delivery Network

Brian Smith
Vice President, Clinical Services
UMass Memorial Specialty Pharmacy

11:30

Networking Luncheon

12:30

VANDERBILT Establishing Partnerships with IDNs to Affect the Patient Journey and Outcomes

Jerry Buller
Director, Specialty Pharmacy Services
Vanderbilt University Medical Center

1:45

JOHNS HOPKINS Optimize Patient Care through Integration and Collaboration

Scott Canfield, PharmD
Clinical Programs Manager, Specialty Pharmacy
Johns Hopkins Home Care Group

2:30

Assess the Impact of Provider Consolidation on Care Coordination Services

Michelle Templin
Vice President, Government Affairs and Business Development
MHA ACO Network

3:15

Close of Conference

Agenda

Want more agenda details? Download the brochure.
Want more agenda details? Download the brochure.

DAY ONE Wednesday, August 16, 2017

7:00

Registration and Continental Breakfast

8:00

Chairperson’s Welcome and Opening Remarks

Gerard Taglianetti
Director, Team Leader, U.S. Payer & Channel Access
Pfizer, Inc

Define Models and Establish Strategies for
Mutually-Beneficial Partnering Relationships

8:15

KEYNOTE PANEL Understanding the Rising Influence of IDNs and HMOs and the Impact on the Healthcare Ecosystem

MODERATOR:

Sarah Foss, PhD
Senior Manager, IDN Message Monitor, Managed Care Message Monitor
Zitter Health Insights

PANELISTS:

Marc O’Connor
Principal, Chief Operating Officer
Curant Health

Jerry Buller
Director, Specialty Pharmacy Services
Vanderbilt University Medical Center

Gerard Taglianetti
Director, Team Leader, U.S. Payer & Channel Access
Pfizer, Inc

John Robicsek
Assistant Vice President, Strategy,
Business and Program Development, Pharmacy Administration
Carolinas Healthcare System

9:15

How Enhancing the Account Management Model Improves IDN Collaboration

Scott Bischoff
Senior Manager, Health Systems Marketing
Teva Pharmaceuticals

Christopher Lisanti
Managing Partner
Exequor Group

10:00

Networking and Refreshment Break

10:30

EXTENDED SESSION Starting from Scratch — Create a Focused Sales Approach

Creating effective relationships with IDNs requires manufacturers to reform their thinking about the customer. This session takes a step-by-step, internal and external approach to engaging large hospital systems and IDNs for the betterment of your product.

I. Choose the Right Partners for Your Brand

II. Identify the Key Decision Makers

III. Build Up Your Team Competency

IV. Become More Customer-Centric — What Does That Mean?

Jeff Prewett
Senior National Account Director - Oncology GPO & IDN
Lilly USA, LLC

Mark Fisher
Senior Manager, Organized Customer Group Commercial Effectiveness, Diabetes/CV Sales
Sanofi US

Wolfgang Freund
Area Sales Director
Sunovion Pharmaceuticals, Inc.

Jeremy Tatum
Director of Sales and Strategic Accounts
American Regent, Inc.

Leverage Data Analytics for
Better Partnership Decision-Making

11:30

Examine Key Characteristics for Defining IDNs and Major Factors for Their Development

Mark Cherry
Principal Analyst, Market Access Insights
Decision Resources Group

12:15

Networking Luncheon

1:30

Gain Insights into Provider Care Coordination and Population Health Management

William T. Lee, DPh, MPA, FASCP
Pharmacy System Director
Carilion Clinic Healthcare System

2:15

Systems of Care — Understanding Network Affiliations and What They May Mean for Your IDN Strategy

Don DeStefano
Director, Life Sciences
LexisNexis Risk Solutions

3:00

Networking and Refreshment Break

3:30

Lessons Learned to Date —
What Makes for a Successful Value Exchange Between Pharma and IDNs?

Will Rose
Managing Consultant
Capgemini Consulting

4:15

Examine Health System Partnerships with External Pharmacies

William Roth
Founding Partner
Blue Fin Group

Andy Pulvermacher
Principal Consultant
Blue Fin Group

5:00

Close of Day One

Networking, Wine and Cheese Reception immediately following the close of day one

DAY TWO Thursday, August 17, 2017

7:00

Continental Breakfast

7:45

Chairperson’s Review of Day One

Gerard Taglianetti
Director, Team Leader, U.S. Payer & Channel Access
Pfizer, Inc

The IDN Evolution and What It Means for Patients

8:00

Importance of Data Visibility to Improve Patient Care and Outcomes

Tom Renshaw, RPh, MCSD, MBA
Senior Director, Business Solutions
Apexus

Rich Gliklich, MD
CEO
OM1 Health

8:45

Biologics and Biosimilars — Regulatory Requirements Impacting EHRs and Pharmacy Systems Used by IDNs

Thomas Felix, MD
R&D Policy, Intercontinental Region (Global Regulatory Affairs and Safety)
Amgen

Pooja Babbrah
Senior Consultant and Practice Lead
Point-of-Care Partners

9:30

From Diagnosis to Delivery — Disruptive Innovation in a Specialty Pharmacy

JoAnn Stubbings, BSPharm, MHCA
Assistant Director, Specialty Pharmacy Services, Ambulatory Care Pharmacy Department
University of Illinois at Chicago College of Pharmacy

10:15

Networking and Refreshment Break

10:45

UMASS MEMORIAL Follow the Patient Journey through an Integrated Delivery Network

Brian Smith
Vice President, Clinical Services
UMass Memorial Specialty Pharmacy

11:30

Networking Luncheon

12:30

VANDERBILT Establishing Partnerships with IDNs to Affect the Patient Journey and Outcomes

Jerry Buller
Director, Specialty Pharmacy Services
Vanderbilt University Medical Center

1:45

JOHNS HOPKINS Optimize Patient Care through Integration and Collaboration

Scott Canfield, PharmD
Clinical Programs Manager, Specialty Pharmacy
Johns Hopkins Home Care Group

2:30

Assess the Impact of Provider Consolidation on Care Coordination Services

Michelle Templin
Vice President, Government Affairs and Business Development
MHA ACO Network

3:15

Close of Conference